- •Preface and Acknowledgments
- •Contents
- •Contributors
- •1: Embryology for Urologists
- •Introduction
- •Renal Development
- •Pronephros
- •Mesonephros
- •Metanephros
- •Development of the Collecting System
- •Critical Steps in Further Development
- •Anomalies of the Kidney
- •Renal Agenesis
- •Renal Aplasia
- •Renal Hypoplasia
- •Renal Ectopia
- •Renal Fusion
- •Ureteral Development
- •Anomalies of Origin
- •Anomalies of Number
- •Incomplete Ureteral Duplication
- •Complete Ureteral Duplication
- •Ureteral Ectopia
- •Embryology of Ectopia
- •Clinical Correlation
- •Location of Ectopic Ureteral Orifices – Male (in Descending Order According to Incidence)
- •Symptoms
- •Ureteroceles
- •Congenital Ureteral Obstruction
- •Pipestem Ureter
- •Megaureter-Megacystis Syndrome
- •Prune Belly Syndrome
- •Vascular Ureteral Obstructions
- •Division of the Urogenital Sinus
- •Bladder Development
- •Urachal Anomalies
- •Cloacal Duct Anomalies
- •Other Bladder Anomalies
- •Bladder Diverticula
- •Bladder Extrophy
- •Gonadal Development
- •Testicular Differentiation
- •Ovarian Differentiation
- •Gonadal Anomalies
- •Genital Duct System
- •Disorders of Testicular Function
- •Female Ductal Development
- •Prostatic Urethral Valves
- •Gonadal Duct Anomalies
- •External Genital Development
- •Male External Genital Development
- •Female External Genital Development
- •Anomalies of the External Genitalia
- •References
- •2: Gross and Laparoscopic Anatomy of the Upper Urinary Tract and Retroperitoneum
- •Overview
- •The Kidneys
- •The Renal Vasculature
- •The Renal Collecting System
- •The Ureters
- •Retroperitoneal Lymphatics
- •Retroperitoneal Nerves
- •The Adrenal Glands
- •References
- •3: Gross and Laparoscopic Anatomy of the Lower Urinary Tract and Pelvis
- •Introduction
- •Female Pelvis
- •Male Pelvis
- •Pelvic Floor
- •Urinary Bladder
- •Urethra
- •Male Urethra
- •Female Urethra
- •Sphincter Mechanisms
- •The Bladder Neck Component
- •The Urethral Wall Component
- •The External Urethral Sphincter
- •Summary
- •References
- •4: Anatomy of the Male Reproductive System
- •Testis and Scrotum
- •Spermatogenesis
- •Hormonal Regulation of Spermatogenesis
- •Genetic Regulation of Spermatogenesis
- •Epididymis and Ductus Deferens
- •Accessory Sex Glands
- •Prostate
- •Seminal Vesicles
- •Bulbourethral Glands
- •Penis
- •Erection and Ejaculation
- •References
- •5: Imaging of the Upper Tracts
- •Anatomy of the Upper Tracts and Introduction to Imaging Modalities
- •Introduction
- •Renal Upper Tract Basic Anatomy
- •Modalities Used for Imaging the Upper Tracts
- •Ultrasound
- •Radiation Issues
- •Contrast Issues
- •Renal and Upper Tract Tumors
- •Benign Renal Tumors
- •Transitional Cell Carcinoma
- •Renal Mass Biopsy
- •Renal Stone Disease
- •Ultrasound
- •Plain Radiographs and IVU
- •Renal Cystic Disease
- •Benign Renal Cysts
- •Hereditary Renal Cystic Disease
- •Complex Renal Cysts
- •Renal Trauma
- •References
- •Introduction
- •Pathophysiology
- •Susceptibility and Resistance
- •Epidemiological Breakpoints
- •Clinical Breakpoints
- •Pharmacodynamic Parameters
- •Pharmacokinetic Parameters
- •Fosfomycin
- •Nitrofurantoin
- •Pivmecillinam
- •b-Lactam-Antibiotics
- •Penicillins
- •Cephalosporins
- •Carbapenems
- •Aminoglycosides
- •Fluoroquinolones
- •Trimethoprim, Cotrimoxazole
- •Glycopeptides
- •Linezolid
- •Conclusion
- •References
- •7: An Overview of Renal Physiology
- •Introduction
- •Body Fluid Compartments
- •Regulation of Potassium Balance
- •Regulation of Acid–Base Balance
- •Diuretics
- •Suggested Reading
- •8: Ureteral Physiology and Pharmacology
- •Ureteral Anatomy
- •Modulation of Peristalsis
- •Ureteral Pharmacology
- •Conclusion
- •References
- •Introduction
- •Afferent Signaling Pathways
- •Efferent Signaling
- •Parasympathetic Nerves
- •Sympathetic Nerves
- •Vesico-Spinal-Vesical Micturition Reflex
- •Peripheral Targets
- •Afferent Signaling Mechanisms
- •Urothelium
- •Myocytes
- •Cholinergic Receptors
- •Muscarinic Receptors
- •Nicotinic Receptors
- •Adrenergic Receptors (ARs)
- •a-Adrenoceptors
- •b-Adrenoceptors
- •Transient Receptor Potential (TRP) Receptors
- •Phosphodiesterases (PDEs)
- •CNS Targets
- •Opioid Receptors
- •Serotonin (5-HT) Mechanisms
- •g-Amino Butyric Acid (GABA) Mechanisms
- •Gabapentin
- •Neurokinin and Neurokinin Receptors
- •Summary
- •References
- •10: Pharmacology of Sexual Function
- •Introduction
- •Sexual Desire/Arousal
- •Endocrinology
- •Steroids in the Male
- •Steroids in the Female
- •Neurohormones
- •Neurotransmitters
- •Dopamine
- •Serotonin
- •Pharmacological Strategies
- •CNS Drugs
- •Enzyme-inducing Antiepileptic Drugs
- •Erectile Function
- •Ejaculatory Function
- •Premature Ejaculation
- •Abnormal Ejaculation
- •Conclusions
- •References
- •Epidemiology
- •Calcium-Based Urolithiasis
- •Uric Acid Urolithiasis
- •Infectious Urolithiasis
- •Cystine-Based Urolithiasis
- •Aims
- •Who Deserves Metabolic Evaluation?
- •Metabolic Workup for Stone Producers
- •Medical History and Physical Examination
- •Stone Analysis
- •Serum Chemistry
- •Urine Evaluation
- •Urine Cultures
- •Urinalysis
- •Twenty-Four Hour Urine Collections
- •Radiologic Imaging
- •Medical Management
- •Conservative Management
- •Increased Fluid Intake
- •Citrus Juices
- •Dietary Restrictions
- •Restricted Oxalate Diet
- •Conservative Measures
- •Selective Medical Therapy
- •Absorptive Hypercalciuria
- •Thiazide
- •Orthophosphate
- •Renal Hypercalciuria
- •Primary Hyperparathyroidism
- •Hyperuricosuric Calcium Oxalate Nephrolithiasis
- •Enteric Hyperoxaluria
- •Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Distal Renal Tubular Acidosis
- •Chronic Diarrheal States
- •Thiazide-Induced Hypocitraturia
- •Idiopathic Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Hypomagnesiuric Calcium Nephrolithiasis
- •Gouty Diathesis
- •Cystinuria
- •Infection Lithiasis
- •Summary
- •References
- •12: Molecular Biology for Urologists
- •Introduction
- •Inherited Changes in Cancer Cells
- •VEGR and Cell Signaling
- •Targeting mTOR
- •Conclusion
- •References
- •13: Chemotherapeutic Agents for Urologic Oncology
- •Introduction
- •Bladder Cancer
- •Muscle Invasive Bladder Cancer
- •Metastatic Bladder Cancer
- •Conclusion
- •Prostate Cancer
- •Other Chemotherapeutic Drugs or Combinations for Treating HRPC
- •Conclusion
- •Renal Cell Carcinoma
- •Chemotherapy
- •Immunotherapy
- •Angiogenesis Inhibitor Drugs
- •Conclusion
- •Testicular Cancer
- •Stage I Seminoma
- •Stage I non-seminomatous Germ Cell Tumours (NSGCT)
- •Metastatic Germ Cell Tumours
- •Low-Volume Metastatic Disease (Stage II A/B)
- •Advanced Metastatic Disease
- •Salvage Chemotherapy for Relapsed or Refractory Disease
- •Conclusion
- •Penile Cancer
- •Side Effects of Chemotherapy
- •Conclusion
- •References
- •14: Tumor and Transplant Immunology
- •Antibodies
- •Cytotoxic and T-helper Cells
- •Immunosuppression
- •Induction Therapy
- •Maintenance Therapy
- •Rejection
- •Posttransplant Lymphoproliferative Disease
- •Summary
- •References
- •15: Pathophysiology of Renal Obstruction
- •Causes of Renal Obstruction
- •Effects on Prenatal Development
- •Prenatal Hydronephrosis
- •Spectrum of Renal Abnormalities
- •Renal Functional Changes
- •Renal Growth/Counterbalance
- •Vascular Changes
- •Inflammatory Mediators
- •Glomerular Development Changes
- •Mechanical Stretch of Renal Tubules
- •Unilateral Versus Bilateral
- •Limitations of Animal Models
- •Future Research
- •Issues in Patient Management
- •Diagnostic Imaging
- •Ultrasound
- •Intravenous Urography
- •Antegrade Urography and the Whitaker Test
- •Nuclear Renography
- •Computed Tomography
- •Magnetic Resonance Urography
- •Hypertension
- •Postobstructive Diuresis
- •References
- •Introduction
- •The Normal Lower Urinary Tract
- •Anatomy
- •Storage Function
- •Voiding Function
- •Neural Control
- •Symptoms
- •Flow Rate and Post-void Residual
- •Voiding Cystometry
- •Male
- •Female
- •Neurourology
- •Conclusions
- •References
- •17: Urologic Endocrinology
- •The Testis
- •Normal Androgen Metabolism
- •Epidemiological Aspects
- •Prostate
- •Brain
- •Muscle Mass and Adipose Tissue
- •Bones
- •Ematopoiesis
- •Metabolism
- •Cardiovascular System
- •Clinical Assessment
- •Biochemical Assessment
- •Treatment Modalities
- •Oral Preparations
- •Parenteral Preparations
- •Transdermal Preparations
- •Side Effects and Treatment Monitoring
- •Body Composition
- •Cognitive Decline
- •Bone Metabolism
- •The Kidneys
- •Endocrine Functions of the Kidney
- •Erythropoietin
- •Calcitriol
- •Renin
- •Paraneoplastic Syndromes
- •Hypercalcemia
- •Hypertension
- •Polycythemia
- •Other Endocrine Abnormalities
- •References
- •General Physiology
- •Prostate Innervation
- •Summary
- •References
- •Wound Healing
- •Inflammation
- •Proliferation
- •Remodeling
- •Principles of Plastic Surgery
- •Tissue Characteristics
- •Grafts
- •Flap
- •References
- •Lower Urinary Tract Symptoms
- •Storage Phase
- •Voiding Phase
- •Return to Storage Phase
- •Urodynamic Parameters
- •Urodynamic Techniques
- •Volume Voided Charts
- •Pad Testing
- •Typical Test Schedule
- •Uroflowmetry
- •Post Voiding Residual
- •Further Diagnostic Evaluation of Patients
- •Cystometry with or Without Video
- •Cystometry
- •Videocystometrography (Cystometry + Cystourethrography)
- •Cystometric Findings
- •Comment:
- •Measurements During the Storage Phase:
- •Measurements During the Voiding Phase:
- •Abnormal Function
- •Disorders of Sensation
- •Causes of Hypersensitive Bladder Sensation
- •Causes of Hyposensitive Bladder Sensation
- •Disorders of Detrusor Motor Function
- •Bladder Outflow Tract Dysfunction
- •Detrusor–Urethral Dyssynergia
- •Detrusor–Bladder Neck Dyssynergia
- •Detrusor–Sphincter Dyssynergia
- •Complex Urodynamic Investigation
- •Urethral Pressure Measurement
- •Technique
- •Neurophysiological Evaluation
- •Conclusion
- •References
- •Endoscopy
- •Cystourethroscopy
- •Ureteroscopy and Ureteropyeloscopy
- •Nephroscopy
- •Virtual Reality Simulators
- •Lasers
- •Clinical Application of Lasers
- •Condylomata Acuminata
- •Urolithiasis
- •Benign Prostatic Hyperplasia
- •Ureteral and Urethral Strictures
- •Conclusion
- •References
- •Introduction
- •The Prostatitis Syndromes
- •The Scope of the Problem
- •Category III CP/CPPS
- •The Goal of Treatment
- •Conservative Management
- •Drug Therapy
- •Antibiotics
- •Anti-inflammatories
- •Alpha blockers
- •Hormone Therapies
- •Phytotherapies
- •Analgesics, muscle relaxants and neuromodulators
- •Surgery
- •A Practical Management Plan
- •References
- •Orchitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment of Infectious Orchitis
- •Epididymitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation of Epididymitis
- •Treatment of Acute Epididymitis
- •Treatment of Chronic Epididymitis
- •Treatment of Spermatic Cord Torsion
- •Fournier’s Gangrene
- •Definition and Etiology
- •Risk Factors
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment
- •References
- •Fungal Infections
- •Candidiasis
- •Aspergillosis
- •Cryptococcosis
- •Blastomycosis
- •Coccidioidomycosis
- •Histoplasmosis
- •Radiographic Findings
- •Treatment
- •Tuberculosis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Schistosomiasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Filariasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Onchocerciasis
- •References
- •25: Sexually Transmitted Infections
- •Introduction
- •STIs Associated with Genital Ulcers
- •Herpes Simplex Virus
- •Diagnosis
- •Treatment
- •Chancroid
- •Diagnosis
- •Treatment
- •Syphilis
- •Diagnosis
- •Treatment
- •Lymphogranuloma Venereum
- •Diagnosis
- •Treatment
- •Chlamydia
- •Diagnosis
- •Treatment
- •Gonorrhea
- •Diagnosis
- •Treatment
- •Trichomoniasis
- •Diagnosis
- •Treatment
- •Human Papilloma Virus
- •Diagnosis
- •Treatment
- •Scabies
- •Diagnosis
- •Treatment
- •References
- •26: Hematuria: Evaluation and Management
- •Introduction
- •Classification of Hematuria
- •Macroscopic Hematuria
- •Microscopic Hematuria
- •Dipstick Hematuria
- •Pseudohematuria
- •Factitious Hematuria
- •Menstruation
- •Aetiology
- •Malignancy
- •Urinary Calculi
- •Infection and Inflammation
- •Benign Prostatic Hyperplasia
- •Trauma
- •Drugs
- •Nephrological Causes
- •Assessment
- •History
- •Examination
- •Investigations
- •Dipstick Urinalysis
- •Cytology
- •Molecular Tests
- •Blood Tests
- •Flexible Cystoscopy
- •Upper Urinary Tract Evaluation
- •Renal USS
- •KUB Abdominal X-Ray
- •Intravenous Urography (IVU)
- •Computed Tomography (CT)
- •Retrograde Urogram Studies
- •Magnetic Resonance Imaging (MRI)
- •Additional Tests and Renal Biopsy
- •Intractable Hematuria
- •Loin Pain Hematuria Syndrome
- •References
- •27: Benign Prostatic Hyperplasia (BPH)
- •Historical Background
- •Pathophysiology
- •Patient Assessment
- •Treatment of BPH
- •Watchful Waiting
- •Drug Therapy
- •Interventional Therapies
- •Conclusions
- •References
- •28: Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie´s Disease
- •Erectile Dysfunction
- •Introduction
- •Diagnosis
- •Basic Evaluation
- •Cardiovascular System and Sexual Activity
- •Optional Tests
- •Treatment
- •Medical Treatment
- •Oral Agents
- •Phosphodiesterase Type 5 (PDE 5) Inhibitors
- •Nonresponders to PDE5 Inhibitors
- •Apomorphine SL
- •Yohimbine
- •Intracavernosal and Intraurethral Therapy
- •Intracavernosal Injection (ICI) Therapy
- •Intraurethral Therapy
- •Vacuum Constriction Devices
- •Surgical Therapy
- •Conclusion
- •Peyronie´s Disease (PD)
- •Introduction
- •Oral Drug Therapy
- •Intralesional Drug Therapy
- •Iontophoresis
- •Radiation Therapy
- •Surgical Therapy
- •References
- •29: Premature Ejaculation
- •Introduction
- •Epidemiology
- •Defining Premature Ejaculation
- •Voluntary Control
- •Sexual Satisfaction
- •Distress
- •Psychosexual Counseling
- •Pharmacological Treatment
- •On-Demand Treatment with Tramadol
- •Topical Anesthetics
- •Phosphodiesterase Inhibitors
- •Surgery
- •Conclusion
- •References
- •30: The Role of Interventional Management for Urinary Tract Calculi
- •Contraindications to ESWL
- •Complications of ESWL
- •PCNL Access
- •Instrumentation for PCNL
- •Nephrostomy Drains Post PCNL
- •Contraindications to PCNL
- •Complications of PCNL
- •Semirigid Ureteroscopy
- •Flexible Ureteroscopy
- •Electrohydraulic Lithotripsy (EHL)
- •Ultrasound
- •Ballistic Lithotripsy
- •Laser Lithotripsy
- •Ureteric Stents
- •Staghorn Calculi
- •Lower Pole Stones
- •Horseshoe Kidneys and Stones
- •Calyceal Diverticula Stones
- •Stones and PUJ Obstruction
- •Treatment of Ureteric Colic
- •Medical Expulsive Therapy (MET)
- •Intervention for Ureteric Stones
- •Stones in Pregnancy
- •Morbid Obesity
- •References
- •Anatomy and Function
- •Pathophysiology
- •Management
- •Optical Urethrotomy/Dilatation
- •Urethral Stents
- •Preoperative Assessment
- •Urethroplasty
- •Anastomotic Urethroplasty
- •Substitution Urethroplasty
- •Grafts Versus Flaps
- •Oral Mucosal Grafts
- •Tissue Engineering
- •Graft Position
- •Conclusion
- •References
- •32: Urinary Incontinence
- •Epidemiology and Risk Factors
- •Pathophysiology
- •Urge Incontinence
- •Conservative Treatments
- •Pharmacotherapy
- •Invasive/ Surgical Therapies
- •Stress Urinary Incontinence
- •Male SUI Therapies
- •Female SUI Therapies
- •Mixed Urinary Incontinence
- •Conclusions
- •References
- •33: Neurogenic Bladder
- •Introduction
- •Examination and Diagnostic Tests
- •History and Physical Examination
- •Imaging
- •Urodynamics (UDS)
- •Evoked Potentials
- •Classifications
- •Somatic Pathways
- •Brain Lesions
- •Cerebrovascular Accident (CVA)
- •Parkinson’s Disease (PD)
- •Multiple Sclerosis
- •Huntington’s Disease
- •Dementias
- •Normal Pressure Hydrocephalus (NPH)
- •Tumors
- •Psychiatric Disorders
- •Spinal Lesions and Pathology
- •Intervertebral Disk Prolapse
- •Spinal Cord Injury (SCI)
- •Transverse Myelitis
- •Peripheral Neuropathies
- •Metabolic Neuropathies
- •Pelvic Surgery
- •Treatment
- •Summary
- •References
- •34: Pelvic Prolapse
- •Introduction
- •Epidemiology
- •Anatomy and Pathophysiology
- •Evaluation and Diagnosis
- •Outcome Measures
- •Imaging
- •Urodynamics
- •Indications for Management
- •Biosynthetics
- •Surgical Management
- •Anterior Compartment Repair
- •Uterine/Apical Prolapse
- •Enterocele Repair
- •Conclusion
- •References
- •35: Urinary Tract Fistula
- •Introduction
- •Urogynecologic Fistula
- •Vesicovaginal Fistula
- •Etiology and Risk Factors
- •Clinical Factors
- •Evaluation and Diagnosis
- •Pelvic Examination
- •Cystoscopy
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Urethrovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Ureterovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Vesicouterine Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Uro-Enteric Fistula
- •Vesicoenteric Fistula
- •Pyeloenteric Fistula
- •Urethrorectal Fistula
- •References
- •36: Urologic Trauma
- •Introduction
- •Kidney
- •Expectant Management
- •Endovascular Therapy
- •Operative Intervention
- •Operative Management: Follow-up
- •Reno-Vascular Injuries
- •Pediatric Renal Injuries
- •Adrenal
- •Ureter
- •Diagnosis
- •Treatment
- •Delayed Diagnosis
- •Bladder and Posterior Urethra
- •Bladder Injuries: Initial Management
- •Bladder Injuries: Formal Repair
- •Anterior Urethral Trauma
- •Fractured Penis
- •Penile Amputation
- •Scrotal and Testicular Trauma
- •Imaging
- •CT-IVP (CT with Delayed Images)
- •Technique
- •Cystogram
- •Technique
- •Retrograde Urethrogram (RUG)
- •Technique
- •Retrograde Pyelogram (RPG)
- •Technique
- •One-Shot IVP
- •Technique
- •References
- •37: Bladder Cancer
- •Who Should Be Investigated?
- •Epidemiology
- •Risk Factors
- •Role of Screening
- •Signs and Symptoms
- •Imaging
- •Cystoscopy
- •Urine Tests
- •PDD-Assisted TUR
- •Pathology
- •NMIBC and Risk Groups
- •Intravesical Chemotherapy
- •Intravesical Immunotherapy
- •Immediate Cystectomy and CIS
- •Radical Cystectomy with Pelvic Lymph Node Dissection
- •sexual function-preserving techniques
- •Bladder-Preservation Treatments
- •Neoadjuvant Chemotherapy
- •Adjuvant Chemotherapy
- •Preoperative Radiotherapy
- •Follow-up After TUR in NMIBC
- •References
- •38: Prostate Cancer
- •Introduction
- •Epidemiology
- •Race
- •Geographic Variation
- •Risk Factors and Prevention
- •Family History
- •Diet and Lifestyle
- •Prevention
- •Screening and Diagnosis
- •Current Screening Recommendations
- •Biopsy
- •Pathology
- •Prognosis
- •Treatment of Prostate Cancer
- •Treatment for Localized Prostate Cancer (T1, T2)
- •Radical Prostatectomy
- •EBRT
- •IMRT
- •Brachytherapy
- •Treatment for Locally Advanced Prostate Cancer (T3, T4)
- •EBRT with ADT
- •Radical Prostatectomy
- •Androgen-Deprivation Therapy
- •Summary
- •References
- •39: The Management of Testis Cancer
- •Presentation and Diagnosis
- •Serum Tumor Markers
- •Primary Surgery
- •Testis Preserving Surgery
- •Risk Stratification
- •Surveillance Versus Primary RPLND
- •Primary RPLND
- •Adjuvant Treatment for High Risk
- •Clinical Stage 1 Seminoma
- •Risk-Stratified Adjuvant Treatment
- •Adjuvant Radiotherapy
- •Adjuvant Low Dose Chemotherapy
- •Primary Combination Chemotherapy
- •Late Toxicity
- •Salvage Strategies
- •Conclusion
- •References
- •Index
5
Imaging of the Upper Tracts
Ferekh Salim
Anatomy of the Upper Tracts and Introduction to Imaging Modalities
Introduction
Imaging plays a central role in the diagnosis and management of many urological conditions. The aim of this chapter is to describe the applications and limitations of various imaging modalities in relation to abnormalities of the upper urinary tract. Particular attention will be given to the important imaging features of conditions seen in everyday urological practice.
Renal Upper Tract Basic Anatomy
The kidneys are situated superiorly in the retroperitoneum and lie obliquely along the plane of the psoas muscles. The right kidney lies medial to the ascending colon and is placed slightly lower than the left kidney due to the mass effect of the right liver lobe of liver.
The left kidney lies inferior to the spleen and is situated medial to the descending colon.
Each kidney consists of an outer cortex and an inner medulla, which consists of several cone shaped structures known as the renal pyramids. The pyramids project into the renal sinus, which is comprised of the pelvicalyceal system (or collecting system), fat, renal vessels, and fibrous supportive tissue.
The kidneys are surrounded by fat that is enclosed by a condensation of fibrous tissue (Gerotas fascia), which outlines the perinephric space.
The major renal vessels enter the kidney through a concave recess at its medial border known as the renal hilum. Typically, the vein enters the hilum anterior to the renal artery with the renal pelvis situated behind the vessels.
The renal collecting systems drain into the ureters, which continue retroperitoneally from the pelviureteric junction to the bladder. The ureter measures approximately 20 cm in length and is lined by transitional cell epithelium. Smooth muscle within the ureteric wall allows peristalsis, facilitating urine flow to the bladder. The ureter is narrowed at the pelviureteric junction, at the level where it crosses the common iliac vessels and at the vesicoureteric junction.
Modalities Used for Imaging the Upper Tracts
Several imaging modalities are available for imaging the upper tracts, namely ultrasound, intravenous urography, isotope renography, CT, and MRI.
Ultrasound
Most solid intra-abdominal organs are well shown by ultrasound. The advantages of ultrasound include its ready availability, relative low
C.R. Chapple and W.D. Steers (eds.), Practical Urology: Essential Principles and Practice, |
69 |
DOI: 10.1007/978-1-84882-034-0_5, © Springer-Verlag London Limited 2011 |
|
|
|
70 |
|
|
|
|
|
|
|
Practical Urology: EssEntial PrinciPlEs and PracticE |
|
cost, and high portability. The absence of any |
medium. An initial control image is usually |
||
associated ionizing radiation makes it particu- |
obtained, which is used to identify renal tract |
||
larly useful in patients where radiation needs to |
calcification. A bolus of intravenous contrast |
||
be avoided, for example, in children or pregnant |
medium is subsequently injected, which is rap- |
||
patients. In order to achieve accurate diagnostic |
idly filtered and excreted by the renal tubules |
||
results, a high degree of operator expertise is |
resulting in enhancement of the renal outlines |
||
necessary. |
and opacification of the pelvicalyceal system, |
||
The kidneys are usually well imaged by ultra- |
ureters, and bladder. |
||
sound making it a valuable first-line test for |
IVU demonstrates the renal outlines allowing |
||
assessment of suspected renal pathology. |
assessment of renal size, position, and morphol- |
||
Visualization of the ureters by ultrasound is |
ogy. Detailed images of the pelvicalyceal systems |
||
variable and frequently limited as a result of |
obtained by IVU allow assessment of the |
||
obscuration by overlying bowel gas. Neverthe- |
mucosal surfaces and can highlight suspicious |
||
less, the proximal and terminal segments can be |
filling defects. |
||
visualized if dilated and are recognizable as |
Delayed excretion and dilatation of the col- |
||
tubular anechoic structures. The renal capsule |
lecting system and ureters indicates renal |
||
can be identified as a well-defined echogenic |
obstruction.1 |
||
line surrounding the kidneys.The cortex appears |
The disadvantages of IVU include the use of |
||
echopoor; prominent sections of cortex known |
ionizing radiation and the associated risks of |
||
as Columns of Bertin (Fig. 5.1) can sometimes |
administration of intravenous contrast, which |
||
be seen indenting the renal sinus. The renal pyr- |
include the possibility of adverse reaction and |
||
amids appear echopoor relative to the cortex |
contrast-induced nephropathy, the latter is of |
||
and can be seen as broad-based triangular |
particular concern in patients with pre existing |
||
structures projecting into the strongly echo- |
renal insufficiency. From a technical viewpoint |
||
genic renal sinus. |
IVU images can be of limited diagnostic value if |
||
|
|
there is poor renal excretion and concentration, |
|
IVU |
or if there is obscuration of the renal tract by |
||
overlying bowel gas shadows. IVU has a low sen- |
|||
Intravenous urogram or IVU is a study of the |
|||
sitivity for the detection of renal cortical masses |
|||
renal tract, which involves the acquisition of a |
and is therefore an inappropriate test if renal |
||
series of abdominal radiographs following |
carcinoma is suspected. Recent years have seen |
||
intravenous injection of iodinated contrast |
a decline in the use of IVU in many centers in |
||
|
|
favor of other imaging techniques such as CT |
|
|
|
urography and MRI. |
Figure 5.1. Ultrasound of a normal kidney, note prominent cortex (column of Bertin) indenting the renal sinus (arrow).
CT
CT is the modality of choice for the imaging of many upper tract conditions. For example, CT has in many centers become the first-line test for detection of ureteric calculi in suspected renal colic. In addition CT is widely accepted as the most useful imaging modality for characterization of renal masses and for the staging of renal malignancies. CT urography refers to a study of the renal tract acquired in the excretory phase following iodinated intravenous contrast injection. Enhancement of the renal parenchyma and opacification of the collecting system and ureters allows detailed evaluation of the entire renal tract. Important applications of CT Urography include investigation of hematuria, and evaluation of hydronephrosis.2
71
imaging of thE UPPEr tracts
The past few years have seen rapid advances |
Radiation Issues |
|
|
|
|
|||
in CT technology. Multidetector row CT (MDCT) |
The radiation doses associated with imaging |
|||||||
provides high resolution imaging coupled with |
||||||||
investigations are relatively small; however, in |
||||||||
fast study times; typically the entire renal tract |
||||||||
order to minimize |
the |
potentially |
harmful |
|||||
can be imaged in less than 30 s. The images are |
||||||||
effects of radiation exposure (such as genetic |
||||||||
acquired in the axial plane; however, multipla- |
||||||||
mutations and malignancy), tests that utilize |
||||||||
nar reformatted (MPR) images, which have spa- |
||||||||
ionizing radiation need to be used judiciously. |
||||||||
tial resolutions similar to the axial images, can |
||||||||
The radiation dose, measured in millisieverts |
||||||||
be generated. 3-D volume-rendered images |
||||||||
(mSv) varies widely between different imaging |
||||||||
(Fig. 5.2) can also be created from the CT data, |
||||||||
tests. For example, the dose estimate from a |
||||||||
which may be useful for surgical planning. |
||||||||
chest radiograph is 0.02 mSv whereas the dose |
||||||||
MRI is able to provide high contrast resolu- |
||||||||
estimate from abdominal CT scan is consider- |
||||||||
tion detailed images of soft tissue structures |
||||||||
ably higher at around 10 mSv. To put this into |
||||||||
and is a useful imaging modality for character- |
||||||||
context, a year’s natural background radiation |
||||||||
ization of renal masses, for the assessment of |
||||||||
from cosmic and terrestrial sources equates to |
||||||||
ureteric obstruction, and for evaluation of the |
||||||||
about 2–3 mSv.3 |
|
|
|
|
||||
renal vasculature. One of the major advantages |
|
|
|
|
||||
In patients where ionizing radiation is of |
||||||||
of MRI includes the absence of ionizing radia- |
||||||||
particular concern, for |
example, |
pregnant |
||||||
tion, which makes it useful for the evaluation of |
||||||||
patients |
and children, |
imaging modalities |
||||||
renal tract pathology in younger patients and in |
||||||||
such as ultrasound and MRI which do not |
||||||||
pregnancy. |
||||||||
involve ionizing radiation should be used if |
||||||||
In the context of urological imaging, the main |
||||||||
possible in preference to high radiation dose |
||||||||
disadvantage of MRI is the poor sensitivity for |
||||||||
tests such as CT. |
|
|
|
|
||||
calcium detection making it unsuitable for the |
|
|
|
|
||||
|
|
|
|
|
|
|||
imaging of renal tract calculi. Other disadvan- |
|
|
|
|
|
|
||
tages include long study times making it unsuit- |
Contrast Issues |
|
|
|
|
|||
able for unstable, confused, or agitated patients. |
|
|
|
|
||||
|
|
|
|
|
|
|||
Cardiac pacemakers are an absolute contraindi- |
Iodinated contrast medium is the most fre- |
|||||||
cation to MRI as there is a risk of pacemaker |
quently used drug in medical imaging and is |
|||||||
malfunction resulting in fatal arrhythmia. |
used in a number of important urological imag- |
|||||||
Nuclear medicine can be used to define split |
ing tests such as CT and intravenous urography. |
|||||||
renal function or to provide an objective analy- |
Although generally considered to be safe, iodine |
|||||||
sis of renal excretory and drainage dynamics. |
contrast medium can provoke an allergic reac- |
|||||||
|
|
tion in a small proportion of patients. The vast |
||||||
|
|
majority of adverse reactions are mild and self- |
||||||
|
|
limiting with serious reactions occurring in |
||||||
|
|
0.04% of cases. Iodinated contrast is therefore |
||||||
|
|
contraindicated in patients with a history of |
||||||
|
|
allergy to iodine. |
|
|
|
|
||
|
|
The other main concern in relation to iodi- |
||||||
|
|
nated contrast media is the risk of inducing |
||||||
|
|
contrast nephrotoxicity, which can lead to |
||||||
|
|
impairment of renal function. Contrast neph- |
||||||
|
|
rotoxicity can be defined as an increase in |
||||||
|
|
serum |
creatinine |
by |
more than |
25% or |
||
|
|
44 mmol/L (0.5 mg/dL) within 3 days following |
||||||
|
|
the intravascular administration of iodinated |
||||||
|
|
contrast medium in the absence of an alterna- |
||||||
|
|
tive cause. |
|
|
|
|
||
|
|
In the majority of cases, impairment of renal |
||||||
|
|
function caused by iodinated contrast is |
||||||
|
|
thought to be transient and self-limiting. |
||||||
|
|
|||||||
Figure 5.2. ct – volume-rendered image of a horseshoe kidney. |
|
However, in patients |
with pre-existing renal |
|||||
|
|
|
|
|
|
|
|